Eagle Pharmaceuticals, Inc. (EGRX)

0.885 0.00 (0.00%) USD  |  OTCM  |  Oct 16, 16:00
More

Eagle Pharmaceuticals Price to Book Value

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 16, 2026 0.046
October 15, 2026 0.0457
October 14, 2026 0.0457
October 13, 2026 0.046
October 12, 2026 0.0504
October 09, 2026 0.0504
October 08, 2026 0.0504
October 07, 2026 0.0504
October 06, 2026 0.0504
October 05, 2026 0.0504
October 02, 2026 0.0504
October 01, 2026 0.0499
September 30, 2026 0.0494
September 29, 2026 0.0533
September 28, 2026 0.0533
September 25, 2026 0.0533
September 24, 2026 0.0468
September 23, 2026 0.0468
September 22, 2026 0.0468
September 21, 2026 0.0468
September 18, 2026 0.0668
September 17, 2026 0.0668
September 16, 2026 0.0668
September 15, 2026 0.0668
September 14, 2026 0.0668
Date Value
September 11, 2026 0.0084
September 10, 2026 0.0392
September 09, 2026 0.039
September 08, 2026 0.039
September 04, 2026 0.039
September 03, 2026 0.039
September 02, 2026 0.0475
September 01, 2026 0.0481
August 31, 2026 0.0481
August 28, 2026 0.0481
August 27, 2026 0.0481
August 26, 2026 0.0356
August 25, 2026 0.0275
August 24, 2026 0.0275
August 21, 2026 0.0275
August 20, 2026 0.0275
August 19, 2026 0.0309
August 18, 2026 0.0309
August 17, 2026 0.0309
August 14, 2026 0.0309
August 13, 2026 0.0309
August 12, 2026 0.0309
August 11, 2026 0.0055
August 10, 2026 0.0036
August 07, 2026 0.0026

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.519
Alnylam Pharmaceuticals, Inc. 22.90
Anika Therapeutics, Inc. 1.948
Savara, Inc. 6.362
Vericel Corp. 5.549

Price to Book Value Related Metrics

Price 0.885
Market Cap 11.59M